A detailed history of Blue Investment Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Blue Investment Partners LLC holds 1,561 shares of ABBV stock, worth $279,731. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,561
Previous 1,561 -0.0%
Holding current value
$279,731
Previous $267,000 15.36%
% of portfolio
0.13%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $14,172 - $15,961
-103 Reduced 6.19%
1,561 $241,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $13,759 - $15,928
103 Added 6.6%
1,664 $248,000
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $19,522 - $22,482
-135 Reduced 7.96%
1,561 $248,000
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $234,573 - $281,315
1,696 New
1,696 $274 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Blue Investment Partners LLC Portfolio

Follow Blue Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Investment Partners LLC with notifications on news.